Patients Beyond one-size-fits-all: How compounding pharmacies address... When it comes to selecting a medication for a patient, there's a growing awareness that one size doesn't fit all.
News Lilly swoops on Morphic to claim IBD drug candidate Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057.
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.